FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to rheumatology, and can be used to diagnose kidney damage in patients with systemic lupus erythematosus (SLE). To do this, simultaneously determine the level of antibodies to xanthine oxidase (anti-KO) in the serum and calculate the coefficient of KO/CDG (xanthine oxidase activity/xanthine dehydrogenase activity). If the upper limit of the level of anti-KO content in the blood serum is exceeded two or more times and the coefficient of KO/CDG is increased by more than 1.5, the presence of signs of kidney damage in patients with SLE is diagnosed.
EFFECT: method allows to increase the accuracy of diagnosis of kidney damage in patients with SLE at early stages of development of the pathological process, that expands the possibilities of timely detection of a category of patients with a high risk of developing renal failure with the possibility of timely prescribing immunosuppressive therapy while improving the quality of life of patients.
1 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF EARLY PREDICTION OF DEVELOPMENT OF NEPHRITIS IN INDUCED MODEL OF SYSTEMIC LUPUS ERYTHEMATOSUS AUTOIMMUNE DISEASE IN VIVO | 2018 |
|
RU2679320C1 |
METHOD OF DIACRISIS OF HEPATOBILIARY SYSTEM DISORDER IN NEWBORN CHILDREN AND CHILDREN OF TENDER AGE OF PERINATAL RISK GROUP | 2008 |
|
RU2389029C1 |
METHOD OF DIFFERENTIAL DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSIS AND RHEUMATISM | 0 |
|
SU1772757A1 |
METHOD OF DETERMINING DEGREE OF ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS | 0 |
|
SU1762228A1 |
DIAGNOSTIC TECHNIQUE FOR RENAL FUNCTIONAL RESERVE | 2012 |
|
RU2528903C2 |
METHOD OF DIFFERENTIAL DIAGNOSIS OF RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS | 0 |
|
SU1812500A1 |
AGENT FOR TREATMENT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSIS | 1997 |
|
RU2157684C2 |
METHOD FOR DETECTING AUTOANTIBODIES AND METHOD FOR PREDICTING AUTOIMMUNE THYROIDITIS | 2006 |
|
RU2315313C2 |
METHOD FOR FORECASTING THE DEVELOPMENT OF NEPHRITIS IN INDUCED MODEL OF SYSTEMIC LUPUS ERYTHEMATOSUS | 2017 |
|
RU2674920C1 |
METHODS OF TREATING CONDITIONS WITH ANTIBODIES THAT BIND COLONY STIMULATING FACTOR 1 RECEPTOR (CSF1R) | 2012 |
|
RU2670743C9 |
Authors
Dates
2019-01-16—Published
2017-05-02—Filed